Trial Profile
A Randomized, Open-Label Trial Comparing Two Avastin (Bevacizumab)-Based Treatment Regimens for the First-Line Treatment of Metastatic Colorectal Cancer
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Genentech
- 03 Jun 2009 New trial record.